Clinical trial
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma…
NCT00076076 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00076076 |
|---|---|
| Title | The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023) |
| Official title | The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Roflumilast |
| Enrollment | 822 |
| Start date | Dec 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Jan 15, 2004 |
| Last update posted | Dec 2, 2016 |
| Countries | Russia, Ukraine, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: